Business News

Novo Nordisk licenses Nanexa drug tech in deal worth up to €1.17 bln

FinSiddhi

Novo Nordisk licenses Nanexa drug tech in deal worth up to €1.17 bln
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

When Preity Zinta recalled breaking down during IVF struggles before twins Jai and Gia’s birth with husband Gene Goodenough: ‘Sometimes I just wanted to bang my head on the wall and cry’

In an honest revelation, Preity Zinta discussed the emotional challenges she faced during her unsuccessful IVF attempts, admitting it was hard to stay positive. Her perseverance paid off when she welcomed twins, Jai and Gia, via surrogacy in 2021. She shared heartfelt thanks to the medical team and surrogate for their invaluable help. Additionally, Zinta…

Gracie Kramer calls out Sydney Sweeney’s Novig ad, sparks bigger debate over how women’s sports are marketed

Former UCLA gymnast Gracie Kramer criticized Sydney Sweeney’s Novig sports ad, saying it sexualizes women instead of showing their skill and hard work. Kramer then shared her own gymnastics footage, starting a wider response from female athletes. Lani Pallister, Amy Hunt, Ariarne Titmus and others followed by showing their training, competitions and achievements while questioning…

Google unveils Gemini 3.7 Flash AI model for coding, agent workflows

Investors have been closely watching for Gemini 3.5 Pro, Google’s premium model, as a test of whether its DeepMind AI unit can keep pace with rivals Anthropic ‌and OpenAI. Google had ⁠said ⁠in July Gemini 3.5 Pro was being tested with partners and would be coming “soon”.